Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of genetics in the risk of thromboembolism: prothrombin 20210A and oral contraceptive therapy.

Journal of the American Academy of Nurse Practitioners - 1 Mar 2004

Welker Glade C, Lookinland Sandra, Tiedeman Mary E, Beckstrand Renea L

Abstract excerpt

PURPOSE: To provide an overview of the prothrombin 20210A mutation, its effects on the incidence of venous thromboembolism (VTE) in users of oral contraceptive therapy (OCT), and screening recommendations for the primary care practice setting. DATA SOURCES: Several databases, including MEDLINE, EMBASE, BIOSIS, Cochrane Library, and SciSearch, were searched for articles published between 1996 and 2003. An...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Contraceptives, Oral, Hormonal
Share to Factor V

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Incidence

Share to Primary Health Care

Share to Prothrombin

Share to Thromboembolism

Share to Venous Thrombosis

Share to Women's Health

Source

Identifiers

PMID: 15130065
DOI: 10.1111/j.1745-7599.2004.tb00381.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of genetics in the risk of thromboembolism: prothrombin 20210A and oral contraceptive therapy.PMID 15130065Read ↗

The prothrombin gene variant 20210A in venous and arterial thromboembolism.Semantic proximity Read ↗

[20210A mutation of the prothrombin and venous thromboembolism gene].Semantic proximity Read ↗

Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis.Semantic proximity Read ↗

Combined Effect of Factor V Leiden and Prothrombin 20210A on the Risk of Venous ThromboembolismSemantic proximity Read ↗

Venous thromboembolism, oral contraceptives and high prothrombin levels.Semantic proximity Read ↗

Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use.Semantic proximity Read ↗

Clinical and laboratory management of the prothrombin G20210A mutation.Semantic proximity Read ↗

Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies.Semantic proximity Read ↗

Global prevalence of prothrombin gene mutation G20210A and implications in women's health: a systematic review.Semantic proximity Read ↗

Risk of thrombosis associated with oral contraceptives of women from 97 families with inherited thrombophilia: high risk of thrombosis in carriers of the G20210A mutation of the prothrombin gene.Semantic proximity Read ↗

Factor V Leiden, prothrombin G20210A substitution and hormone therapy: indications for molecular screening.Semantic proximity Read ↗

Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.